In experimental colitis mouse models, REV-ERBα demonstrates significant anti-inflammatory properties by specifically inhibiting NF-κB and Nlrp3 expression, effectively reducing Nlrp3 inflammasome activity [184]. This evidence concerns the gene NLRP3 and colitis.